Categories: News

TeleMedicine Platform for Sale

ORLANDO, Fla., Jan. 15, 2021 /PRNewswire/ — TeleDaddy, a direct-to-consumer telemedicine platform taking care of everything from diagnosis by US-licensed physicians to the delivery of prescribed medication to our patients, is looking for strategic buyer or sale. https://app.teledaddy.com

TeleMedicine Platform Highlights
– SureScripts Certified to send prescription electronically to 65,000 Pharmacy across US.
– Video consultation
– SMS
– Symptoms & Diagnostic AI
– HIPAA Compliant
– Drug Interaction checker
– Electronic Consent Sign
– E-Rx
– LegitScript Certified

Pharmacy Highlights
– Physical Pharmacy Location in Florida
– 25+ Active State License
– Active DEA License
– All Major Insurance
Capabilities
– Direct to Consumer Subscription offering of ED Meds, Birth Control, Migraine, Hair Loss, Skincare etc.
– HUB Pharmacy
– Manufacturer solutions for Branded Medications
– Online Pharmacy
– Online Telemedicine platform

Example of Strategic Buyer:
– Groupon: Groupon can extend Health service offering of online pharmacy & telemedicine to their current customer with addition of TeleDaddy platform.
– Venture Capital

Example of Competitor:
– For Hims 
– Get Roman

Media Contact
Ankit Patel
407-625-4320
289225@email4pr.com 

 

View original content to download multimedia:http://www.prnewswire.com/news-releases/telemedicine-platform-for-sale-301209194.html

SOURCE TeleDaddy

Staff

Recent Posts

Universal Brain Announces Publication of Groundbreaking Depression Research Using Multiple Event-Related Potentials

New findings support the company's neuroscience-driven approach to precision psychiatry, offering actionable insights for personalized…

2 hours ago

Iktos and Cube Biotech Announce Launch of Small Molecule AI Drug Discovery Collaboration

Partnership will leverage Iktos's AI-enabled drug discovery platform and Cube Biotech's advanced protein technologies to…

2 hours ago

MimiVax and UI Pharmaceuticals Achieve Milestone in SurVaxM Production for Glioblastoma Treatment

SurVaxM is the first drug product to be produced in UI Pharmaceuticals new facilityUI Pharmaceuticals…

2 hours ago

RingConn Takes Center Stage at CES 2025 with Innovative Wearables: Gen 2 and Gen 2 Air

LAS VEGAS, Jan. 10, 2025 /PRNewswire/ -- RingConn, a leading smart wearable brand, is proud…

2 hours ago

1933 Industries Provides Update on Status of Filing Delay for 4th Quarterly Report and Announces Management Changes

VANCOUVER, BC / ACCESSWIRE / January 10, 2025 / 1933 Industries Inc. (the "Company" or…

2 hours ago